(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

PMC

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

PMC

ST13

US500000079303122

Classe

35, 42, 44, 45

Pedido

79303122

Registro

6504732

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

34

Atualização mais recente

18/04/2022

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

35, 42, 44, 45

Data de depósito

26/08/2020

Data de registro

05/10/2021

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

05/10/2021

Última transação

05/10/2021

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Código do desenho

4

Tipo de titular

24

Localização do titular

GB

Examinador

DINALLO, KEVIN

Unidade examinadora

L70

Localização atual

PUBLICATION AND ISSUE SECTION

Titulares e representantes

Titulares

PharmaMedic Consultancy Limited

Representantes

William C Wright Epstein Drangel LLP

Classificação técnica

Classes Nice

Classe 35Classe 42Classe 44Classe 45

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 35

Business project management; Business intelligence services; Business analysis; Business data analysis; Business strategy development and planning; Design and development of marketingpublicity and advertising materials; Development and planning of marketingpublicity and advertising strategies; Business introductionbusiness networking services; Business representationpublic relations agency services; Consultancyadvisory and information services relating to all of the foregoing; Businessmarketingpublicityadvertisingbusiness risk management and business development and formation consultancyadvisory and information services

Classe 42

Industrial analysis and industrial research in the fields of medicinebiotechnology and pharmacy and in the field of medical devicesmachinesinstrumentsequipment and apparatus; Industrial design services; Quality control and quality authentication services in the fields of medicinebiotechnology and pharmacy and in the field of medical devicesmachinesinstrumentsequipment and apparatus; Medical and pharmaceutical research; Design and development of medicalpharmaceutical and clinical studies; Design and development of medical experimentstreatments and procedures; Design and development of clinical protocols; Analysis and evaluation of medicines and pharmaceuticals; Analysis and evaluation of medical devicesmachinesinstrumentsequipment and apparatus; Consultancyadvisory and information services relating to all of the foregoing; Design and development of packaging; Medical writingpreparation of regulatory documentation relating to medicines and pharmaceuticals

Classe 44

Pharmacovigilance servicesthe identificationdetectionassessmentanalysismonitoring and prevention of adverse effects in relation to pharmaceuticals; Consultancyadvisory and information services relating to all of the foregoing; Medical and pharmaceutical consultancyadvisory and information services; Consultancyadvisory and information services relating to medicines and pharmaceuticals and to the operation and efficacy of medical devicesmachinesinstrumentsequipment and apparatus

Classe 45

Legal services; Legal services in relation to representation before regulatory authorities; Consultancyadvisory and information services relating to all of the foregoing; Consultancyadvisory and information services relating to legal and regulatory affairs in the fields of medicine and pharmacy and in the field of medical devicesmachinesinstrumentsequipment and apparatus

Publicações

Histórico de despachos e eventos da marca no USPTO.

34 publicações encontradas

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

18/04/2022

FICS

FINAL DISPOSITION NOTICE SENT TO IB

25/03/2022

FIMP

FINAL DISPOSITION PROCESSED

25/03/2022

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

05/01/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

05/10/2021

CREV

CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED

21/07/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

20/07/2021

PUBO

PUBLISHED FOR OPPOSITION

20/07/2021

RINX

USPTO CORRECTION PROCESSED BY IB

10/07/2021

CRCV

CORRECTION TRANSACTION RECEIVED FROM IB

10/07/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

30/06/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

17/06/2021

XAEC

EXAMINER'S AMENDMENT ENTERED

17/06/2021

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

17/06/2021

GNEA

EXAMINERS AMENDMENT E-MAILED

17/06/2021

CNEA

EXAMINERS AMENDMENT -WRITTEN

17/06/2021

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

15/06/2021

GNFR

FINAL REFUSAL E-MAILED

15/06/2021

CNFR

FINAL REFUSAL WRITTEN

15/06/2021

CRSN

CORRECTION SENT TO IB

09/06/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/06/2021

CRCR

CORRECTION CREATED FOR IB

09/06/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

08/06/2021

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

08/06/2021

RFNT

REFUSAL PROCESSED BY IB

05/04/2021

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

12/03/2021

RFRR

REFUSAL PROCESSED BY MPU

12/03/2021

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

06/03/2021

CNRT

NON-FINAL ACTION WRITTEN

05/03/2021

MAFR

APPLICATION FILING RECEIPT MAILED

09/02/2021

DOCK

ASSIGNED TO EXAMINER

03/02/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

03/02/2021

LIMI

LIMITATION FROM ORIGINAL APPLICATION ENTERED

02/02/2021

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

28/01/2021

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace PMC ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.